Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross Profit | $23.7B | $26.5B | $27.9B | $31.1B | $32.9B | $37.1B | $40.4B | $38.8B | $39.2B | $36.3B | $33.0B | $31.9B | $33.0B | $34.8B | $34.3B | $34.8B | $37.0B | $36.3B | $34.2B | $38.9B |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Novartis AG's last 12-month Gross Profit is $38.2B, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, Novartis AG's Gross Profit growth was 4.3%. The average annual Gross Profit growth rates for Novartis AG have been 2.3% over the past three years, 2.2% over the past five years.
Over the last year, Novartis AG's Gross Profit growth was 4.3%, which is higher than industry growth of 0.2%. It indicates that Novartis AG's Gross Profit growth is Good.